N/A
N=213
Single Session Class to Reduce Opioid Use in Chronic Pain
Chronic Pain
Bottom Line
View on ClinicalTrials.gov: NCT03950791 ↗Enrolled (actual)
213
Serious AEs
0.5%
Results posted
Nov 2024
Primary outcome: Primary: Opioid Use — -6.7; -8.0 MME — p=.89
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Pain Catastrophizing Class (Behavioral); Health Education (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Stanford University
- Primary completion
- May 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Opioid Use |
-6.7; -8.0 | .89 |
Summary
Prescription opioids are one of the most commonly used treatments for chronic pain, despite limited evidence of their efficacy and high morbidity and mortality risks. The study aims to determine the efficacy of a targeted single-session psychology class in reducing opioid use among patients with chronic pain. The information gained from this study has the potential to identify patients who achieve a meaningful reduction in opioid use and inform opioid reduction strategies.
Eligibility Criteria
Inclusion Criteria
- 18-80 years of age
- Diagnosis of chronic non-cancer pain (> 3 months in duration)
- Currently using prescription opioids ≥ 10mg morphine equivalent daily dose (MEDD) for ≥ 3 months;
- Ability and willingness to complete study procedures.
Exclusion Criteria
- Open litigation regarding a medical condition
- Inability to provide informed consent and complete study procedures
- Previous experience with cognitive behavioral therapy (CBT)
- Active suicidality.
Data sourced from ClinicalTrials.gov (NCT03950791). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.